Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

A novel drug for Tuberculosis

Reference number
Coordinator Karolinska Institutet - Institutionen för medicin, Huddinge
Funding from Vinnova SEK 1 200 000
Project duration November 2002 - June 2004
Status Completed

Last updated 28 January 2020

Reference number 2002-01866